Compounds > imipenem, anhydrous
Page last updated: 2024-08-26

imipenem, anhydrous and Inflammation

imipenem, anhydrous has been researched along with Inflammation in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's2 (20.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Al-Madboly, LA1
Hashemi, SM; Hosseini, AZ; Khaligh, SG; Khosrojerdi, A; Soudi, S1
Jiang, C; Liu, L; Liu, N; Xie, N; Xu, Y; Zhang, G1
Chen, XG; Fu, FH; Jiang, WL; Qu, GW; Tian, JW; Yue, XD; Zhu, HB1
Chen, XG; Fu, FH; Gao, YB; Jiang, WL; Tian, JW; Zhu, HB1
Hou, J; Jiang, WL; Xu, Y; Zhang, SP; Zhu, HB1
Amâncio, RT; Bozza, FA; Bozza, PT; Castro-Faria-Neto, HC; David, CM; Gomes, RN; Vianna, RC1
Eron, LJ; Goldenberg, RI; Hixon, DL; Park, CH; Poretz, DM1
Andrews, JM; Donovan, IA; Drumm, J; Lockley, MR; Wise, R1
Hashizume, T; Ogashiwa, M; Okumoto, Y; Shimano, K1

Trials

1 trial(s) available for imipenem, anhydrous and Inflammation

ArticleYear
Imipenem versus moxalactam in the treatment of serious infections.
    Antimicrobial agents and chemotherapy, 1983, Volume: 24, Issue:6

    Topics: Adult; Aged; Bacterial Infections; Female; Humans; Imipenem; Inflammation; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Thienamycins

1983

Other Studies

9 other study(ies) available for imipenem, anhydrous and Inflammation

ArticleYear
A Novel Triple Combination To Combat Serious Infections with Carbapenem-Resistant Acinetobacter baumannii in a Mouse Pneumonia Model.
    Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Ascorbic Acid; Biological Factors; Carbapenems; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Inflammation; Mice; Microbial Sensitivity Tests; Pneumonia; Transferrins

2022
The combination of mesenchymal stem cell- and hepatocyte-derived exosomes, along with imipenem, ameliorates inflammatory responses and liver damage in a sepsis mouse model.
    Life sciences, 2023, Aug-01, Volume: 326

    Topics: Animals; Cytokines; Exosomes; Hepatocytes; Imipenem; Inflammation; Liver; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Sepsis

2023
Treatment with andrographolide sulfonate provides additional benefits to imipenem in a mouse model of Klebsiella pneumoniae pneumonia.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 117

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cell Movement; Disease Models, Animal; Diterpenes; Humans; Imipenem; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice, Inbred C57BL; Monocyte Chemoattractant Proteins; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; Survival Analysis; THP-1 Cells

2019
Rosmarinic acid protects against experimental sepsis by inhibiting proinflammatory factor release and ameliorating hemodynamics.
    Shock (Augusta, Ga.), 2009, Volume: 32, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Cinnamates; Depsides; Disease Models, Animal; Endotoxins; Gene Expression Regulation; Hemodynamics; Humans; Imipenem; Inflammation; Male; Mice; Myeloid Cells; Rats; Rats, Sprague-Dawley; Rosmarinic Acid; Sepsis; Tretinoin

2009
Paeoniflorin inhibits systemic inflammation and improves survival in experimental sepsis.
    Basic & clinical pharmacology & toxicology, 2009, Volume: 105, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Blood Urea Nitrogen; Bridged-Ring Compounds; Cecum; Cell Line; Clinical Enzyme Tests; DNA-Binding Proteins; Endotoxins; Glucosides; Hemodynamics; Imipenem; Inflammation; Inflammation Mediators; Intestine, Small; Lactic Acid; Liver; Lung; Macrophages; Male; Membrane Glycoproteins; Mice; Monoterpenes; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; Shock, Septic; Triggering Receptor Expressed on Myeloid Cells-1

2009
Protocatechuic aldehyde protects against experimental sepsis in vitro and in vivo.
    Basic & clinical pharmacology & toxicology, 2012, Volume: 110, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Benzaldehydes; Catechols; Cell Line; Disease Models, Animal; Drug Therapy, Combination; HMGB1 Protein; Imipenem; Inflammation; Inflammation Mediators; Injections, Intravenous; Interleukin-10; Macrophages; Male; NF-kappa B; Phosphorylation; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha

2012
Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
    Shock (Augusta, Ga.), 2004, Volume: 21, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cecum; Ciprofloxacin; Clindamycin; Colony-Forming Units Assay; Cytokines; Disease Models, Animal; Endotoxins; Enzyme-Linked Immunosorbent Assay; Female; Gram-Negative Bacteria; Imipenem; Inflammation; Interleukin-10; Interleukin-6; Leukocytes; Lipopolysaccharides; Male; Mice; Sepsis; Time Factors; Tumor Necrosis Factor-alpha

2004
The pharmacokinetics and tissue penetration of imipenem.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl E

    Topics: Adult; Bacillus subtilis; Body Fluids; Exudates and Transudates; Humans; Imipenem; Inflammation; Kinetics; Male; Peritoneum; Thienamycins

1986
Penetration of imipenem and other antibiotics into inflammatory exudate and their efficacy in pseudomonas infection in the rat granuloma pouch model.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Cefazolin; Cefotaxime; Cefsulodin; Ceftizoxime; Exudates and Transudates; Granuloma; Imipenem; Inflammation; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Thienamycins

1987